Sun Mountain Capital

Uvera Inc. is a technology company based in San Mateo, California, established in 2019. It specializes in developing innovative ultraviolet (UV) light technology that effectively extends the shelf life of fresh food. Uvera's portable devices utilize this technology to disinfect food from viruses, bacteria, and foodborne pathogens without the use of chemicals. The technology can double the shelf life of fresh produce, meat, and baked goods, typically achieving an average extension of up to 60% within just 30 seconds of application. Uvera's products cater to both consumers and the food and beverage industry, addressing the critical need for enhanced food preservation solutions.

Green Theme Technologies Inc is a company that specializes in developing environmentally-friendly chemical technology for the finishing of textiles and nonwovens. Founded in 2012 and based in Rio Rancho, New Mexico, the company focuses on creating innovative products that enhance performance while significantly reducing water usage and pollution associated with traditional textile finishing processes. By prioritizing sustainability, Green Theme Technologies aims to revolutionize the textile industry with its advanced solutions.

Vega Cloud is a software-as-a-service (SaaS) application focused on managing public cloud infrastructure. It offers an enterprise management platform that simplifies the complexities of cloud deployment, allowing businesses to efficiently scale their operations. The platform provides optimization recommendations, helping organizations streamline their cloud management processes. By utilizing Vega Cloud, companies can save both time and money in their cloud deployments, making it easier to oversee their infrastructure effectively.

3D Glass Solutions, Inc. specializes in manufacturing glass-based system-in-package (SiP) electronic packaging devices and components. The company offers a range of services, including design consultation and prototyping, catering to integrated circuit manufacturers, photonic component suppliers, and defense contractors. Utilizing its patented APEX® Glass technology, 3D Glass Solutions provides complete glass-enabled systems integration, enabling clients to consolidate multiple components onto a single platform while reducing overall manufacturing costs. The firm also develops photo-definable components such as bandpass filters, gain antennas, and discrete LC components, employing low-loss photosensitive technology to deliver industry-specific radio frequency devices. Established in 2006, 3D Glass Solutions is headquartered in Albuquerque, New Mexico.

Armonica Technologies is an early-stage medtech company specializing in long-read DNA sequencing technology aimed at precision medicine applications. Named after Benjamin Franklin's Glass Armonica, the company has developed a proprietary platform that can sequence a complete human genome in minutes. This innovative technology utilizes nanochannels to guide single nucleic acid molecules through nanopores, allowing for optical readout through Raman spectroscopy. By overcoming the limitations of existing sequencing technologies, Armonica's platform offers life science researchers and clinicians a comprehensive understanding of the genome, including critical insights into all epigenetic modifications. The company holds a portfolio of patented and patent-pending technologies licensed from STC.UNM, positioning it at the forefront of advancements in genomic sequencing.

BayoTech, Inc. is a company specializing in the development and manufacture of hydrogen generation systems, including steam methane reformers. Founded in 2015 and based in Albuquerque, New Mexico, BayoTech focuses on advancing hydrogen innovation and sustainability by providing low-carbon hydrogen solutions aimed at reducing transportation emissions and optimizing the supply chain through local production. The company operates a network of hydrogen production hubs, known as BayoGaaS® Hydrogen Hubs, with sites in Wentzville, Missouri, and an upcoming facility in Stockton, California. Additionally, BayoTech manufactures high-capacity, high-pressure transport trailers in Tulsa, Oklahoma, to ensure safe and reliable distribution of hydrogen. The company's comprehensive portfolio includes solutions for hydrogen production, transport, storage, and fueling, making low-carbon hydrogen accessible and cost-effective for various sectors, including agriculture, fuel cells, and energy.

First Crop is engaged in the development of farming technology that promotes environmentally sustainable practices for farmers. The company focuses on regenerative principles, including financial inclusion, empowered participation, and resource sharing. By providing USDA certified-organic hemp, First Crop enables the production of high-quality hemp-derived health and wellness products. This approach not only supports farmers in adopting sustainable methods but also facilitates easier access to CBD products for users.

UbiQD, LLC is a cleantech materials company based in Los Alamos, New Mexico, that specializes in the production of low-hazard quantum dots and nanocomposites. Founded in 2014, UbiQD aims to make its innovative materials widely accessible for various applications, including agriculture, safety, design, solar energy, lighting, security, and personal care. The company offers UbiGro, a retrofit luminescent film designed to enhance crop growth by optimizing sunlight in greenhouses. UbiQD's low-toxicity quantum dots are engineered to efficiently convert light from one color to another, making them suitable for a range of industries while adhering to safety standards. The firm's strategic location near Los Alamos and Sandia National Laboratory facilitates valuable collaborations with leading scientists, furthering its mission to advance nanomaterial production and application.

BennuBio, Inc. is a technology company specializing in the development of flow cytometry equipment designed for the sorting and analysis of cells and particles in various applications, particularly those requiring the recovery of rare cells. The company offers The Velocyt system, which enables the detection of rare events such as activated T cells, circulating tumor cells, and fetal cells in maternal blood, supporting advancements in personalized medicine and drug discovery. Additionally, BennuBio provides spheroid generation systems and high-volume sorting systems, along with technical and application support services. Founded in 2018 and based in Albuquerque, New Mexico, BennuBio focuses on delivering innovative cell analysis solutions that accommodate a wide range of sample sizes and particle dimensions.

mPower Technology, Inc. is a manufacturer of interconnected meshes of miniature solar cells, founded in 2014 and headquartered in Albuquerque, New Mexico. The company specializes in developing semiconductor active miniature solar cells tailored for the space, terrestrial, and Internet of Things (IoT) industries. By utilizing advanced materials and processes from the silicon photovoltaic and microelectronics sectors, mPower Technology provides a flexible solar solution that overcomes the limitations of traditional silicon and gallium arsenide solar cells. This innovation allows clients to enhance the performance and longevity of solar cells even in challenging environments, such as those encountered in space, where on-orbit radiation recovery is critical. The company's experienced team aims to advance solar power technology on a global scale.

Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

3D Glass Solutions, Inc. specializes in manufacturing glass-based system-in-package (SiP) electronic packaging devices and components. The company offers a range of services, including design consultation and prototyping, catering to integrated circuit manufacturers, photonic component suppliers, and defense contractors. Utilizing its patented APEX® Glass technology, 3D Glass Solutions provides complete glass-enabled systems integration, enabling clients to consolidate multiple components onto a single platform while reducing overall manufacturing costs. The firm also develops photo-definable components such as bandpass filters, gain antennas, and discrete LC components, employing low-loss photosensitive technology to deliver industry-specific radio frequency devices. Established in 2006, 3D Glass Solutions is headquartered in Albuquerque, New Mexico.

Robotic Skies, Inc. is a provider of maintenance and repair services for commercial unmanned aircraft systems (UAS) and advanced air mobility aircraft (AAM). Founded in 2013 and based in Albuquerque, New Mexico, the company operates a global network of over 150 independently-owned repair stations. These stations are staffed by aviation professionals with expertise in maintaining both manned and unmanned aircraft, ensuring high standards of safety and efficiency. Robotic Skies offers a comprehensive field service program designed to keep UAS fleets operational and compliant with aviation regulations. This approach enables it to deliver specialized certification, maintenance, and repair services to emerging commercial drone operators worldwide.

BennuBio, Inc. is a technology company specializing in the development of flow cytometry equipment designed for the sorting and analysis of cells and particles in various applications, particularly those requiring the recovery of rare cells. The company offers The Velocyt system, which enables the detection of rare events such as activated T cells, circulating tumor cells, and fetal cells in maternal blood, supporting advancements in personalized medicine and drug discovery. Additionally, BennuBio provides spheroid generation systems and high-volume sorting systems, along with technical and application support services. Founded in 2018 and based in Albuquerque, New Mexico, BennuBio focuses on delivering innovative cell analysis solutions that accommodate a wide range of sample sizes and particle dimensions.

RiskSense, Inc. specializes in cyber risk management solutions, offering a cloud-based platform that enables organizations to assess and manage their cybersecurity risks effectively. The RiskSense Platform allows users to evaluate their cyber risk exposure across a broad attack surface, orchestrate remediation efforts, and monitor outcomes. Key services include RiskSense Vulnerability Discovery, which provides regular vulnerability assessments to identify security weaknesses, and RiskSense Attack Surface Validation, which assesses vulnerabilities that could be exploited by cyber adversaries. The platform employs risk-based scoring and analytics to present a comprehensive view of cybersecurity risks, allowing organizations to prioritize remediation activities based on critical security weaknesses. Founded in 2006 and headquartered in Sunnyvale, California, RiskSense also has offices in Albuquerque, New Mexico, and India.

Agilvax, Inc. is a biotechnology company based in Albuquerque, New Mexico, focused on developing targeted vaccine therapies for infectious diseases and chronic conditions. Founded in 2011, the company utilizes a virus-like particle platform technology to create immunotherapies aimed at cancer and other diseases. Its lead candidate, AXO3, is designed for HPV prevention, while Agilvax is also exploring vaccine products for a range of conditions, including asthma, dengue, malaria, autoimmune diseases, and various metabolic and rare diseases. The company follows a rigorous process of identifying and optimizing vaccine candidates through in vitro and in vivo testing, progressing them through pre-clinical and clinical stages to establish proof of concept. Agilvax actively seeks collaborations and partnerships across the pharmaceutical, biotech, academic, and government sectors to enhance its research and development efforts.

BayoTech, Inc. is a company specializing in the development and manufacture of hydrogen generation systems, including steam methane reformers. Founded in 2015 and based in Albuquerque, New Mexico, BayoTech focuses on advancing hydrogen innovation and sustainability by providing low-carbon hydrogen solutions aimed at reducing transportation emissions and optimizing the supply chain through local production. The company operates a network of hydrogen production hubs, known as BayoGaaS® Hydrogen Hubs, with sites in Wentzville, Missouri, and an upcoming facility in Stockton, California. Additionally, BayoTech manufactures high-capacity, high-pressure transport trailers in Tulsa, Oklahoma, to ensure safe and reliable distribution of hydrogen. The company's comprehensive portfolio includes solutions for hydrogen production, transport, storage, and fueling, making low-carbon hydrogen accessible and cost-effective for various sectors, including agriculture, fuel cells, and energy.

Armonica Technologies is an early-stage medtech company specializing in long-read DNA sequencing technology aimed at precision medicine applications. Named after Benjamin Franklin's Glass Armonica, the company has developed a proprietary platform that can sequence a complete human genome in minutes. This innovative technology utilizes nanochannels to guide single nucleic acid molecules through nanopores, allowing for optical readout through Raman spectroscopy. By overcoming the limitations of existing sequencing technologies, Armonica's platform offers life science researchers and clinicians a comprehensive understanding of the genome, including critical insights into all epigenetic modifications. The company holds a portfolio of patented and patent-pending technologies licensed from STC.UNM, positioning it at the forefront of advancements in genomic sequencing.

Robotic Skies, Inc. is a provider of maintenance and repair services for commercial unmanned aircraft systems (UAS) and advanced air mobility aircraft (AAM). Founded in 2013 and based in Albuquerque, New Mexico, the company operates a global network of over 150 independently-owned repair stations. These stations are staffed by aviation professionals with expertise in maintaining both manned and unmanned aircraft, ensuring high standards of safety and efficiency. Robotic Skies offers a comprehensive field service program designed to keep UAS fleets operational and compliant with aviation regulations. This approach enables it to deliver specialized certification, maintenance, and repair services to emerging commercial drone operators worldwide.

TriLumina Corporation, established in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly vertical-cavity surface-emitting lasers (VCSEL) for advanced illumination solutions. The company focuses on applications in 3D sensing and LiDAR technology, catering to automotive, industrial, and mobile markets. TriLumina's patented VCSEL innovations support the rapid development of next-generation technologies, making them a preferred choice for various applications, including augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Their products are designed for integration into Time-of-Flight and Long Range LiDAR systems, as well as in-cabin applications, and have attained automotive Grade 1 temperature range AEC-Q102 qualification, ensuring high performance and reliability for clients in demanding environments.

RiskSense, Inc. specializes in cyber risk management solutions, offering a cloud-based platform that enables organizations to assess and manage their cybersecurity risks effectively. The RiskSense Platform allows users to evaluate their cyber risk exposure across a broad attack surface, orchestrate remediation efforts, and monitor outcomes. Key services include RiskSense Vulnerability Discovery, which provides regular vulnerability assessments to identify security weaknesses, and RiskSense Attack Surface Validation, which assesses vulnerabilities that could be exploited by cyber adversaries. The platform employs risk-based scoring and analytics to present a comprehensive view of cybersecurity risks, allowing organizations to prioritize remediation activities based on critical security weaknesses. Founded in 2006 and headquartered in Sunnyvale, California, RiskSense also has offices in Albuquerque, New Mexico, and India.

SBA Materials, Inc. specializes in the development and commercialization of advanced electronic materials tailored for the semiconductor manufacturing industry, particularly in back-end of line and packaging applications. Founded in 2001 and based in Albuquerque, New Mexico, the company focuses on low-k dielectric materials for interlayer dielectric applications, addressing significant needs in the sector. Its product offerings include uLK22, uLK1X, and various optical films, along with nano-porous and meso-porous materials. These materials can be utilized in diverse forms such as thin films, powders, and fibers, and can be chemically functionalized for applications in electronics, optics, sensors, and catalysts. The company operates from a facility at the Science and Technology Park, which features R&D laboratories and is strategically located near the University of New Mexico and the Sandia National Laboratories Materials Research Center. SBA Materials aims to enhance the performance of electronic devices while reducing power consumption, thereby supporting manufacturers in producing more efficient logic chips.

Seamless Medical Systems, LLC specializes in developing cloud-based software and services aimed at enhancing the operational efficiency of physician practices while improving patient communication. Its flagship product, SNAP Practice, serves as a comprehensive patient engagement platform that facilitates data capture, registration, and health education. The company also offers SNAP EXPRESS, a patient engagement tool that includes features such as digital registration and personalized health education, as well as SNAP ENTERPRISE, which integrates with electronic medical records and practice management systems. Additional offerings include SNAPedu, an educational platform delivering health information at the point of care, and SNAPdash, a dashboard providing insights into patient registration workflows. Seamless Medical Systems caters to a diverse range of healthcare practitioners across the United States, and is based in Santa Fe, New Mexico. The company was incorporated in 2010 and operates as a subsidiary of GetWellNetwork, Inc.

TriLumina Corporation, established in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly vertical-cavity surface-emitting lasers (VCSEL) for advanced illumination solutions. The company focuses on applications in 3D sensing and LiDAR technology, catering to automotive, industrial, and mobile markets. TriLumina's patented VCSEL innovations support the rapid development of next-generation technologies, making them a preferred choice for various applications, including augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Their products are designed for integration into Time-of-Flight and Long Range LiDAR systems, as well as in-cabin applications, and have attained automotive Grade 1 temperature range AEC-Q102 qualification, ensuring high performance and reliability for clients in demanding environments.

Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, established in 2010. The company specializes in the pulmonary delivery of therapeutics aimed at addressing respiratory diseases with unmet medical needs. Respira focuses on the development and commercialization of passive dry powder inhalers (DPIs) that utilize a novel drug delivery engine and mechanism of action for effective lung therapy. The company has achieved clinical proof-of-principle for its technology, which has demonstrated superior drug dispersion performance compared to existing devices. This positions Respira's DPIs to potentially replace currently marketed inhalation devices and expand inhaled therapies across various drug classes and disease indications, particularly in high-value therapeutic areas. Additionally, Respira maintains a strategic collaboration with United Therapeutics Corporation to further its objectives in this field.

Aspen Avionics, headquartered in Albuquerque, New Mexico, was established in 2004 by a group of aviation enthusiasts. The company focuses on developing advanced avionics products aimed at enhancing situational awareness and reducing pilot workload in general aviation. Aspen Avionics offers affordable solutions that allow aircraft owners to upgrade traditional primary flight instruments to modern glass cockpit technology without incurring significant costs or complicated installation processes. Its products are designed to improve safety and ease of flying in both visual and instrument flight rules conditions.

Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, established in 2010. The company specializes in the pulmonary delivery of therapeutics aimed at addressing respiratory diseases with unmet medical needs. Respira focuses on the development and commercialization of passive dry powder inhalers (DPIs) that utilize a novel drug delivery engine and mechanism of action for effective lung therapy. The company has achieved clinical proof-of-principle for its technology, which has demonstrated superior drug dispersion performance compared to existing devices. This positions Respira's DPIs to potentially replace currently marketed inhalation devices and expand inhaled therapies across various drug classes and disease indications, particularly in high-value therapeutic areas. Additionally, Respira maintains a strategic collaboration with United Therapeutics Corporation to further its objectives in this field.

SBA Materials, Inc. specializes in the development and commercialization of advanced electronic materials tailored for the semiconductor manufacturing industry, particularly in back-end of line and packaging applications. Founded in 2001 and based in Albuquerque, New Mexico, the company focuses on low-k dielectric materials for interlayer dielectric applications, addressing significant needs in the sector. Its product offerings include uLK22, uLK1X, and various optical films, along with nano-porous and meso-porous materials. These materials can be utilized in diverse forms such as thin films, powders, and fibers, and can be chemically functionalized for applications in electronics, optics, sensors, and catalysts. The company operates from a facility at the Science and Technology Park, which features R&D laboratories and is strategically located near the University of New Mexico and the Sandia National Laboratories Materials Research Center. SBA Materials aims to enhance the performance of electronic devices while reducing power consumption, thereby supporting manufacturers in producing more efficient logic chips.

Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

xF Technologies Inc. specializes in the production of specialty chemicals by converting renewable biomass materials, such as cornstarch and sugarcane, into nontoxic and sustainable chemical products. The company offers a range of products, including methyl, ethyl, and isopropyl compounds, as well as plasticizers for the PVC market and various solvents for cleaning and processing applications. Additionally, xF Technologies develops innovative biofuels and petrochemical replacements through its patented molecular platform, which enhances environmental performance while providing cost savings. Founded in 2007 and headquartered in Albuquerque, New Mexico, the company aims to deliver solutions that improve environmental health and safety ratings across various industries, including agriculture, personal care, and paints and coatings.

TriLumina Corporation, established in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly vertical-cavity surface-emitting lasers (VCSEL) for advanced illumination solutions. The company focuses on applications in 3D sensing and LiDAR technology, catering to automotive, industrial, and mobile markets. TriLumina's patented VCSEL innovations support the rapid development of next-generation technologies, making them a preferred choice for various applications, including augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Their products are designed for integration into Time-of-Flight and Long Range LiDAR systems, as well as in-cabin applications, and have attained automotive Grade 1 temperature range AEC-Q102 qualification, ensuring high performance and reliability for clients in demanding environments.

xF Technologies Inc. specializes in the production of specialty chemicals by converting renewable biomass materials, such as cornstarch and sugarcane, into nontoxic and sustainable chemical products. The company offers a range of products, including methyl, ethyl, and isopropyl compounds, as well as plasticizers for the PVC market and various solvents for cleaning and processing applications. Additionally, xF Technologies develops innovative biofuels and petrochemical replacements through its patented molecular platform, which enhances environmental performance while providing cost savings. Founded in 2007 and headquartered in Albuquerque, New Mexico, the company aims to deliver solutions that improve environmental health and safety ratings across various industries, including agriculture, personal care, and paints and coatings.

Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, established in 2010. The company specializes in the pulmonary delivery of therapeutics aimed at addressing respiratory diseases with unmet medical needs. Respira focuses on the development and commercialization of passive dry powder inhalers (DPIs) that utilize a novel drug delivery engine and mechanism of action for effective lung therapy. The company has achieved clinical proof-of-principle for its technology, which has demonstrated superior drug dispersion performance compared to existing devices. This positions Respira's DPIs to potentially replace currently marketed inhalation devices and expand inhaled therapies across various drug classes and disease indications, particularly in high-value therapeutic areas. Additionally, Respira maintains a strategic collaboration with United Therapeutics Corporation to further its objectives in this field.

xF Technologies Inc. specializes in the production of specialty chemicals by converting renewable biomass materials, such as cornstarch and sugarcane, into nontoxic and sustainable chemical products. The company offers a range of products, including methyl, ethyl, and isopropyl compounds, as well as plasticizers for the PVC market and various solvents for cleaning and processing applications. Additionally, xF Technologies develops innovative biofuels and petrochemical replacements through its patented molecular platform, which enhances environmental performance while providing cost savings. Founded in 2007 and headquartered in Albuquerque, New Mexico, the company aims to deliver solutions that improve environmental health and safety ratings across various industries, including agriculture, personal care, and paints and coatings.

TriLumina Corporation, established in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly vertical-cavity surface-emitting lasers (VCSEL) for advanced illumination solutions. The company focuses on applications in 3D sensing and LiDAR technology, catering to automotive, industrial, and mobile markets. TriLumina's patented VCSEL innovations support the rapid development of next-generation technologies, making them a preferred choice for various applications, including augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Their products are designed for integration into Time-of-Flight and Long Range LiDAR systems, as well as in-cabin applications, and have attained automotive Grade 1 temperature range AEC-Q102 qualification, ensuring high performance and reliability for clients in demanding environments.

Aspen Avionics, headquartered in Albuquerque, New Mexico, was established in 2004 by a group of aviation enthusiasts. The company focuses on developing advanced avionics products aimed at enhancing situational awareness and reducing pilot workload in general aviation. Aspen Avionics offers affordable solutions that allow aircraft owners to upgrade traditional primary flight instruments to modern glass cockpit technology without incurring significant costs or complicated installation processes. Its products are designed to improve safety and ease of flying in both visual and instrument flight rules conditions.

Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

Comet Solutions, Inc. specializes in developing engineering simulation applications aimed at enhancing the automation of modeling and simulation tasks in product development. Founded in 2001 and headquartered in Cincinnati, Ohio, the company offers a range of software solutions, including SimApps and Gearbox SimApps, which allow manufacturers to conduct "what if?" analyses, assess design modifications, and optimize performance across various domains such as acoustics, dynamics, durability, and cost management. These applications facilitate collaboration among design and engineering teams by enabling non-experts to perform simulations and adhere to best practices. Additionally, Comet Solutions provides a process automation platform for computer-aided engineering (CAE), simulation templates, and consulting services. Its products cater to diverse industries, including space systems, consumer products, electronics, and automotive applications. Comet Solutions also maintains offices in Albuquerque, New Mexico; Troy, Michigan; Shanghai, China; and India.

Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

Skorpios Technologies, Inc. is a fabless semiconductor company based in Albuquerque, New Mexico, specializing in silicon photonic integrated circuit products. Founded in 2009, the company develops and markets a range of opto-electronic integrated circuits, including 100G-CWDM system-on-chip receivers and transmitters. Skorpios Technologies also offers innovative solutions such as Template Assisted Bonding, which supports high-speed video, data, and voice communications across networking, cloud computing, storage, and cable TV applications. Additionally, the company provides gain materials, wafer-scale processes, uncooled tunable laser technology, and coherent transceiver devices. By designing and manufacturing integrated optical modules and subsystems, Skorpios enables high-bandwidth interconnectivity at competitive manufacturing costs, serving various sectors including aerospace and defense, bioelectronics, and communications.

NanoMR specializes in the development of blood diagnostic devices, focusing on the rapid isolation of rare cells from complex biological samples at concentrations as low as one cell per milliliter. The company's innovative immunomagnetic capture system allows for the simultaneous targeting of multiple cell types, enabling the efficient extraction of bacteria and fungi in cases of bloodstream infections, as well as specific cells such as circulating tumor or fetal cells. This process is completed in under 30 minutes, significantly enhancing the speed and accuracy of diagnostics in clinical settings.

Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

JackRabbit Systems is a technology company focused on serving the global travel industry. It develops a comprehensive platform that includes a booking referral engine, event management software, and marketing performance insights data. Additionally, the company provides event marketing tools and channel distribution solutions, all designed to equip travel companies with software that generates actionable insights. By offering these innovative solutions, JackRabbit Systems aims to enhance efficiency and effectiveness in travel marketing and event management.

NanoMR specializes in the development of blood diagnostic devices, focusing on the rapid isolation of rare cells from complex biological samples at concentrations as low as one cell per milliliter. The company's innovative immunomagnetic capture system allows for the simultaneous targeting of multiple cell types, enabling the efficient extraction of bacteria and fungi in cases of bloodstream infections, as well as specific cells such as circulating tumor or fetal cells. This process is completed in under 30 minutes, significantly enhancing the speed and accuracy of diagnostics in clinical settings.

Lumidigm Inc. is a biometric technology company focused on delivering secure and reliable identification and verification solutions. The company specializes in developing identification technology that utilizes optical skin tissue measurements to produce high-quality images consistently, regardless of environmental conditions. Lumidigm's biometric identity management services are applicable across various sectors, including civil identification, point-of-sale systems, time and attendance tracking, and both physical and logical access control. Additionally, their technology extends to portable electronic device applications, ensuring that everyone is identifiable in a convenient manner.

Aspen Avionics, headquartered in Albuquerque, New Mexico, was established in 2004 by a group of aviation enthusiasts. The company focuses on developing advanced avionics products aimed at enhancing situational awareness and reducing pilot workload in general aviation. Aspen Avionics offers affordable solutions that allow aircraft owners to upgrade traditional primary flight instruments to modern glass cockpit technology without incurring significant costs or complicated installation processes. Its products are designed to improve safety and ease of flying in both visual and instrument flight rules conditions.

Advent Solar, based in Albuquerque, New Mexico, specializes in the production of silicon photovoltaic cells and modules. The company focuses on advanced technology that enhances the efficiency and design of solar energy solutions. Through its patented Ventura Technology, Advent Solar offers a comprehensive cell-to-module architecture that aims to deliver high-performance solar modules with significant value. The company operates a licensing model to distribute its innovative intellectual property, positioning itself as a leader in the solar industry. Advent Solar is committed to advancing solar technology and improving smart grid economics through its cutting-edge products.